- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01816737
Fetal Blood Flow Response to Partial Occlusion by External Compression
March 21, 2013 updated by: Meir Medical Center
Two earlier studies showed measurable fetal hemodynamics changes caused by external pressure induced by te abdominal ultrasound transducer.
The investigators would like to study the response of flow in main fetal vessels to different, mild to moderate pressures induced by the abdominal transducer.
The pressure induced by the transducer will be measured by a digital computed manometer.
The flow chances in fetal vessels will be measured by ultrasound Doppler.
Measurements will be taken on different pregnancy weeks, on one occasion in each pregnant woman.
Ones without applying transducer pressure (control) and ones after applying mild pressure.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
50
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
pregnant women
Description
Inclusion Criteria:
singleton
Exclusion Criteria:
multiple gestation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
pulsatility index in fetal vessels
Time Frame: at the time of pressure aplication
|
at the time of pressure aplication
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Anticipated)
October 1, 2013
Study Registration Dates
First Submitted
March 20, 2013
First Submitted That Met QC Criteria
March 21, 2013
First Posted (Estimate)
March 22, 2013
Study Record Updates
Last Update Posted (Estimate)
March 22, 2013
Last Update Submitted That Met QC Criteria
March 21, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- MMC13191-12CTIL
- 0191-12-MMC (Other Identifier: Helsinki committee , MeirMc, Israel)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Age
-
Tel-Aviv Sourasky Medical CenterUnknownSmall for Gestational Age Infants | Appropriate for Gestational Age InfantsIsrael
-
Société des Produits Nestlé (SPN)CompletedSmall for Gestational Age (SGA) Infants | Appropriate for Gestational Age (AGA) InfantsIndia
-
Gynuity Health ProjectsUniversity of Pennsylvania; Planned Parenthood of Southeastern PennsylvaniaCompletedGestational AgeUnited States
-
Aga Khan UniversityUniversity of Colorado, Denver; International Atomic Energy AgencyCompletedMicronutrients | Gestational AgePakistan
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S., an affiliate of Merck KGaA, Darmstadt, GermanyCompleted
-
Xiamen Amoytop Biotech Co., Ltd.RecruitingSmall for Gestational AgeChina
-
SandozCompletedSmall for Gestational AgeBelgium, Czechia, Georgia, Hungary, Poland, Romania, Germany
-
Aljazeera HospitalKasr El Aini Hospital; National Research Centre, EgyptUnknown
-
PfizerCompletedSmall for Gestational Age
-
GeneScience Pharmaceuticals Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsUnknownSmall for Gestational Age InfantChina